Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 3, 1996, Pages 1128-1135

  Rosen, Marc I ^a   McMahon, Thomas J ^a   Hameedi, Faiq A ^a   Pearsall, H Rowland ^a   Woods, Scott W ^a   Kreek, Mary Jeanne ^b   Kosten, Thomas R ^a  

^a Yale University School of Medicine   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030111338     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. BRASE, D. A., IWAMOTO, E. T., LOH, H. H. AND WAY, E. L.: Reinitiation of sensitivity to naloxone by a single narcotic injection in post-addicted mice. J. Pharmacol. Exp. Ther. 197: 317-325, 1976.
2. BUCCAFUSCO, J: Neuropharmacologic and behavioral actions of clonidine: Interactions with central neurotransmitters. Inter. Rev. Neurobiol. 33: 55-107, 1992
3. CARLSON, D. E. AND GANN, D. S.: Alpha-adrenergic input in the locus ceruleus modulates plasma adrenocorticotropin in cats: Endocrinology 130: 2795-2803, 1992.
4. 2-adrenergic and opiate receptor blockade: Synergistic effects on anxiety in healthy subjects. Arch. Gen. Psychiatry 43: 1037-1041, 1986.
5. CHARNEY, D. S., STERNBERG, D. E., KLEBER, H. D., HENINGER, G. R. AND REDMOND, E: The clinical use of clonidine in abrupt withdrawal from methadone Arch. Gen Psychiatry 38: 1273-1277, 1981.
6. FISCHMAN, M. W , FOLTIN, R. W., NESTADT, G. AND PEARLSON, G. D.: Effects of desipramine maintenance on cocaine self-administered by humans. J. Pharmacol. Exp. Ther. 253: 760-770, 1990.
7. GOLD, M. S., POTTASH, A. C., SWEENEY, D. R. AND KLEBER, H. D.: Opiate withdrawal using clonidine. J. Am. Med. Assoc. 243: 343-346, 1980.
8. GROSSMAN, A. AND BESSER, G. M.: Opiates control ACTH through a noradrenergic mechanism. Clin. Endocrinol. 17: 287-290, 1982.
9. GUILLEMIN, R., VANGO, J., ROSSIER, J., MINICK, S., LING, W., RIVIER, C., VALE, W. AND BLOOM, F: Beta-endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. Science (Wash. DC) 197: 1367-1369, 1977
10. HANDELSMAN, L , COCHRANE, K. J., ARONSON, M. J., NESS, R., RUBINSTEIN, K. J. AND KANOF, P D.: Two new rating scales for opiate withdrawal. Am. J Drug Alcohol Abuse 13: 293-308, 1987.
11. HIGGINS, G. A. AND SELLERS, E. M.: Antagonist-precipitated opioid withdrawal in rats: Evidence for dissociations between physiological and motivational signs. Pharmacol. Biochem. Behav. 48: 1-8, 1994.
12. ISBELL, H. AND FRASER, H. F.: Actions and addiction liabilities of dromoran derivatives in man. J. Pharmacol. Exp. Ther. 107: 524-530, 1953.
13. JACKSON, R. V., GRICE, J. E., JACKSON, A. J. AND HOCKINGS, G. I.: Naloxone-induced ACTH release in man is inhibited by clonidine. Clin. Exp. Pharmacol. Physiol. 17: 179-184, 1990.
14. JACQUET, Y. F.: Opiate effects after andrenocorticotropin or beta-endorphin injection in the periaqueductal gray matter of rats. Science (Wash. DC) 201: 1032-1034, 1979.
15. JAFFE, J. H. AND MARTIN, W. R.: Opioid analgesics and antagonists. In The Pharmacological Basis of Therapeutics, 7th ed., ed. by A. G. Gillman, L. S. Goodman, T. W. Rail and F. Murad, pp. 491-531. MacMillan Publishing Company, New York, 1985.
16. JASINSKI, D. R.: Assessment of the abuse potential of morphine like drugs (methods used in man). In Drug Addiction I, ed. by W. R. Martin, pp. 197-258. Springer-Verlag, New York, 1977.
17. JASINSKI, D. R., JOHNSON, R. E. AND KOCHER, T. R.: Clonidine in morphine withdrawal. Arch. Gen. Psychiatry 42: 1063-1066, 1985.
18. KENNEDY, J. A., HARTMAN, N., SBRIGLIO, R., KHURI, E. AND KREEK, M. J.: Metyrapone-induced withdrawal symptoms. Br. J. Addiction 85: 1133-1140, 1990
19. KOOB, G. F., WALL, T. L. AND BLOOM, F. E.. Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacology 98: 530-534, 1989.
20. KOSTEN, T. A., JACOBSEN, L. K. AND KOSTEN, T. R.: Severity of precipitated opiate withdrawal predicts drug dependence by DSM-III-R criteria. Am. J. Drug Alcohol Abuse 15: 237-250, 1989.
21. LANES, R., HERRERA, A., PALACIOS, A. AND MONCADA, G: Decreased secretion of cortisol and ACTH after oral clonidine administration in normal adults. Metabolism 32: 568-570, 1983.
22. MALDONADO, R., STINUS, L., GOLD, L. H. AND KOOB, G. F.: Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261: 669-677, 1992.
23. MARSHALL, I. AND WEINSTOCK, M: Quantitative method for assessing one symptom of the withdrawal syndrome in mice after chronic morphine administration Nature 234: (Lond.) 223-224, 1971.
24. MEYER, D. R. AND SPARBER, S. B ; Clonidine antagonized body weight loss and other symptoms used to measure withdrawal in morphine-pelleted rats given naloxone. Pharmacologist 18: 236, 1976.
25. MITCHELL, P., SMYTHE, G., PARKER, G., WILHELM, K., BRODATY, H., BOYCE, P. AND HICKIE, I: Growth hormone and other hormonal responses to clonidine in melancholic and nonmelancholic depressed subjects and controls. Psych. Res. 37: 179-193, 1991.
26. NABER, D., PICKAR, D., DAVIS, G. C., COHEN, R. M., JIMERSON, D. C., ELCHISAK, M. A., DEFRAITES, E. G., KALIN, N. H., RISCH, S. C. AND BUCHSBAUM, M. S : Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA, MHPG in plasma of normal volunteers. Psychopharmacology 74: 125-128, 1981.
27. PEACHEY, J. E. AND LEI, H: Assessment of opioid dependence with naloxone. Br. J. Addict. 83: 193-201, 1988.
28. PETTINGER, W. A.: Clonidine, a new antihypotensive drug. N. Engl. J. Med. 293: 1179-1180, 1975.
29. PRANZATELLI, M. R : On the molecular mechanism of adrenocorticotrophic hormone in the CNS: Neurotransmitters and receptors. Exp. Neurol. 125: 142-161, 1994.
30. PRESTON, K. L., BIGELOW, G. E AND LIEBSON, I. A.: Antagonist effects of nalbuphine in opioid-dependent human volunteers. J. Pharmacol. Exp. Ther. 248: 929-937, 1989.
31. REDMOND, D. E. AND KRYSTAL, J. H.: Multiple mechanisms of withdrawal from opioid drugs. Annu. Rev. Neurosci. 7: 443-478, 1984.
32. REID, I. A., AHN, J. N., TRINH, T., SHACKELFORD, R., WEINTRAUB, M. AND KEIL, L. C.: Mechanism of suppression of vasopressin and andrenocorticotropic hormone secretion by clonidine in anesthetized dogs. J Pharmacol. Exp Ther. 229: 1-8, 1984.
33. ROSEN, M. I., MCMAHON, T. J., MARGOLIN, A., GILL, T. S., WOODS, S. W., PEARSALL, H. R., KREEK, M. J. AND KOSTEN, T. R.: Reliability of sequential naloxone challenge tests. Am. J. Drug Alcohol Abuse 21: 453-467, 1995.
34. RUDOLPH, C. D., KAPLAN, S. L. AND GANONG, W. F.: Sites at which elonidine acts to affect blood pressure and the secretion of renin, growth hormone and ACTH. Neuroendocrinology 31: 121-128, 1980.
35. 2-adrenergic agonist clonidine. Biol. Psychiatry 19; 131-156, 1984.
36. 1-24 blocks opiate-induced analgesia in the rat. Brain Res. 212: 202-206, 1981.
37. STRAIN, E. C., PRESTON, K. P., LIEBSON, I. A. AND BIGELOW, G. E.: Acute effects of buprenorphine, hydromorphone, and naloxone in methadone-maintained volunteers. J. Pharmacol. Exp. Ther 261: 985-993, 1992.
38. TAYLOR, J. R., ELSWORTH, J. D., GARCIA, E. J., GRANT, S. J., ROTH, R. H. AND REDMOND, D. E., JR.: Clonidine infusions into the locus ceruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology 96: 121-134, 1988.
39. VINING, E., KOSTEN, T. R. AND KLEBER, H. D.: Clinical utility of rapid clonidinenaltrexone detoxification of opioid abusers. Br. J. Addict 83: 567-575, 1988.
40. VOLAVKA, J , CHO, D. AND MALLYA, A: Naloxone increases ACTH and cortisol levels in man. N. Engl. J. Med. 300: 1056-1057, 1979.
41. WANG, R. I., KOCHAR, C., HASEGAWA, A. T. AND ROH, B. L.: Initial methadone dose in treating opiate addiction. Int. J. Addict. 17: 357-363, 1982.
42. WAY, EL, LOH, H. H. AND SHEN, F. H.: Simultaneous quantitative assessment of morphine tolerance and physical dependence. J. Pharmacol. Exp. Ther. 167: 1-8, 1969.
43. WIKLER, A., FRASER, H. F. AND ISBELL, H: N-allylnormorphine: Effects of single doses and precipitation of acute "abstinence syndromes" during addiction to morphine, methadone or heroin in man (postaddicts). J. Pharmacol. Exp. Ther. 109: 8-20, 1953.
44. WOOD, P. L., MALTHE-SORENSSEN, D., CHENEY, D. L. AND COSTA, E.: Increase of hippocampal acetylcholine turnover rate and the stretching-yawning syndrome elicited by alpha-MSH and ACTH. Life Sci. 22: 673-678, 1978
45. ZILM, D H AND SELLERS, E. M.: The quantitative assessment of physical dependence on opiates Drug Alcohol Depend. 3: 419-428, 1978.